Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma
Clinical trial NCT01956695 · COMPLETED
Trial details
- NCT number
- NCT01956695
- Sponsor
- Institut Curie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-18
- Primary completion
- 2018-01-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.